The OriCol™ device provides samples containing a range of biomarkers to enable clinical analysis and research and development into Gastrointestinal Diseases.

OriCol samples enable clinical diagnosisCLINICAL APPLICATIONS

OriCol™ is a convenient and effective method of sample collection for in vitro analyses using existing tests and clinical workflow to enable diagnosis and monitoring of GI diseases including:

  • Colorectal Cancer (CRC)

  • Inflammatory Bowel Diseases (IBD) including Crohn’s Disease and Ulcerative Colitis

  • Irritable Bowel Syndrome (IBS)

  • GI Infections

  • Pancreatic Cancer

  • Allergies and Food Intolerance


OriCol™ may be used during the development of a Companion Diagnostic for GI disease, enabling the safe and convenient biomarker sample collection. Companion Diagnostics are assays intended to assist physicians in making treatment decisions for their patients. They do so by elucidating the efficacy and/or safety of a specific drug or class of drugs for a targeted patient group or sub-groups.

Bacteria in the human gut microbiomeRESEARCH AND DEVELOPMENT

OriCol™ is a valuable tool for generating biologically informative samples for research and development into the following:

  • GI diseases such as CRC, IBD, IBS

  • Human Gut Microbiome

  • Allergies and Food Intolerance

  • Bacterial Infections